Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.4 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.065 | 0.4 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |